Literature DB >> 10691792

Nitric oxide-angiotensin II interactions in angiotensin II-dependent hypertension.

L G Navar1, A Ichihara, S Y Chin, J D Imig.   

Abstract

Many studies indicate that renal haemodynamic function in angiotensin II- (ANG II) dependent hypertension is not reduced as much as would be predicted from the elevated ANG II levels suggesting that counteracting renoprotective mechanisms are activated. One important renoprotective effect is mediated by increased levels of nitric oxide. Recent studies using the ANG II-infused hypertensive rat model have shown that inhibition of nitric oxide synthesis (NOS) causes greater decreases in renal blood flow and glomerular filtration rate in ANG II-infused hypertensive rats than in control rats. This augmented nitric oxide-dependent influence is localized primarily in the cortex and to the preglomerular vasculature. The differential effects on the renal cortex and medulla are also reflected by the differences in NOS activities and protein expression. Ca2+-dependent NOS activity was significantly greater in the cortex but not the medulla of the ANG II-infused hypertensive rats compared with control rats. This was associated with marked activation of endothelial NOS protein levels and smaller increases in neuronal NOS protein levels in the cortex but not in the medulla. In contrast, the Ca2+-independent NOS activity and the inducible NOS protein levels in the cortex were significantly lower in the ANG II-infused hypertensive rats. These data support the hypothesis that cortical Ca2+-dependent NOS, primarily endothelial NOS, is stimulated during the early phases of ANG II-induced hypertension and exerts a renoprotective effect on cortical haemodynamics.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10691792     DOI: 10.1046/j.1365-201x.2000.00630.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  12 in total

Review 1.  Renal renin-angiotensin system.

Authors:  Atsuhiro Ichihara; Hiroyuki Kobori; Akira Nishiyama; L Gabriel Navar
Journal:  Contrib Nephrol       Date:  2004       Impact factor: 1.580

2.  Angiotensin II-induced hypertension blunts thick ascending limb NO production by reducing NO synthase 3 expression and enhancing threonine 495 phosphorylation.

Authors:  Vanesa D Ramseyer; Agustin Gonzalez-Vicente; Oscar A Carretero; Jeffrey L Garvin
Journal:  Am J Physiol Renal Physiol       Date:  2014-11-05

3.  Exogenous L-arginine ameliorates angiotensin II-induced hypertension and renal damage in rats.

Authors:  Niwanthi W Rajapakse; Carmen De Miguel; Satarupa Das; David L Mattson
Journal:  Hypertension       Date:  2008-11-03       Impact factor: 10.190

4.  Protective actions of estrogen on angiotensin II-induced hypertension: role of central nitric oxide.

Authors:  Baojian Xue; Minati Singh; Fang Guo; Meredith Hay; Alan Kim Johnson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-09-04       Impact factor: 4.733

Review 5.  Role of glomerular filtration rate in controlling blood pressure early in diabetes.

Authors:  Michael W Brands; Hicham Labazi
Journal:  Hypertension       Date:  2008-07-07       Impact factor: 10.190

6.  Exogenous L-arginine attenuates the effects of angiotensin II on renal hemodynamics and the pressure natriuresis-diuresis relationship.

Authors:  Satarupa Das; David L Mattson
Journal:  Clin Exp Pharmacol Physiol       Date:  2014-04       Impact factor: 2.557

7.  Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established: a study in Cyp1a1-Ren-2 transgenic rats.

Authors:  Šárka Jíchová; Libor Kopkan; Zuzana Husková; Šárka Doleželová; Jan Neckář; Petr Kujal; Zdenka Vernerová; Herbert J Kramer; Janusz Sadowski; Elzbieta Kompanowska-Jezierska; Rami N Reddy; John R Falck; John D Imig; Luděk Červenka
Journal:  J Hypertens       Date:  2016-10       Impact factor: 4.844

8.  Blood pressure, blood flow, and oxygenation in the clipped kidney of chronic 2-kidney, 1-clip rats: effects of tempol and Angiotensin blockade.

Authors:  Fredrik Palm; Maristela Onozato; William J Welch; Christopher S Wilcox
Journal:  Hypertension       Date:  2010-01-04       Impact factor: 10.190

9.  Antihypertensive and renoprotective actions of soluble epoxide hydrolase inhibition in ANG II-dependent malignant hypertension are abolished by pretreatment with L-NAME.

Authors:  Zuzana Honetschlägerová; Kento Kitada; Zuzana Husková; Alexandra Sporková; Libor Kopkan; Marcela Bürgelová; Šárka Varcabová; Akira Nishiyama; Sung Hee Hwang; Bruce D Hammock; John D Imig; Herbert J Kramer; Petr Kujal; Zdenka Vernerová; Luděk Červenka
Journal:  J Hypertens       Date:  2013-02       Impact factor: 4.844

10.  Soluble epoxide hydrolase inhibition exhibits antihypertensive actions independently of nitric oxide in mice with renovascular hypertension.

Authors:  Libor Kopkan; Zuzana Husková; Alexandra Sporková; Šárka Varcabová; Zuzana Honetschlägerová; Sung Hee Hwang; Hsing-Ju Tsai; Bruce D Hammock; John D Imig; Herbert J Kramer; Marcela Bürgelová; Alžběta Vojtíšková; Petr Kujal; Zdenka Vernerová; Luděk Červenka
Journal:  Kidney Blood Press Res       Date:  2012-08-29       Impact factor: 2.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.